Case Reports of DRESS Syndrome and Symptoms Consistent with DRESS Syndrome Following Treatment with Recently Marketed Monoclonal Antibodies

Table 1

Full results of the case study screen organized by reporter and monoclonal antibody.

Reporter	Monoclonal Antibody	Cutaneous Adverse Effect
Rauer et. al.	Daclizumab	DRESS syndrome
	Daclizumab	DRESS syndrome
Naidoo et. al.	Nivolumab	Drug-induced hypersensitivity dermatitis
	Ipilimumab/Nivolumab	Maculopapular rash, vesicles, erosions
	Ipilimumab/Durvalumab	Lichenoid dermatitis, blisters, exanthema
Fontecilla et. al.	Durvalumab/Tremelimumab	Epidermal necrolysis, eosinophilic infiltrate
Oiwa et. al.	Ixekizumab	Psoriasiform eruptions
Anthony et. al.	Ixekizumab	Pruritic, photosensitive plaques
Maria et. al.	Ixekizumab	Lentiginous eruption
Hayashida et. al.	Secukinumab	Pemphigus vulgaris
Thompson et. al.	Secukinumab	Ulcerative lichenoid mucositis
Al Hammadi & Parmar	Dupilumab	Erythema, pruritus and diffuse skin peeling
Takahashi et. al.	Brodalumab	Palmar pustular eruption